Resiquimod hydrogel

N/A

Report date: 2025/06/06 14:53:36

Base Information

Drug NameResiquimod hydrogel
Drug Alias NameSTM-416pSTM-416STM0416 SURGERx
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionToll like receptor 7 agonistsToll like receptor 8 agonistsInterferon alpha stimulants
TargetsToll like receptor 7Toll like receptor 8Interferon alpha
Therapy Area/IndicationsProstatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesAustralia
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesSurge Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesSurge Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsProstatic Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A